SEYSARA

Peak

sarecycline hydrochloride

Almirall
NDAORALTABLET
Approved
Oct 2018
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Feb 9, 2033
84 months away
Patent Expiry
Feb 9, 2033

Patent Records (4)

Patent #ExpiryTypeUse Code
9481639
Aug 10, 2028
U-2409
8513223
Dec 7, 2029
U-2406
8318706
Jan 3, 2032
SubstanceProduct
U-2405
9255068
Feb 9, 2033
SubstanceProduct
U-2407
Company
Almirall
Almirall
Spain - Barcelona
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers